BridgeMD
New treatment option for Stroke
Official title Perceptions of RehAtt Mixed Reality System
ClinicalTrials.gov ID: NCT06641336
What this study is testing
- What it's testing
- The study aims to explore the patients' perspective on usability and feasibility of the RehAtt™ mixed-reality system during upper limb, gait and balance function rehabilitation.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- first ischaemic or hemorrhagic stroke,
- one-sided hemiparesis,
- adequate cognitive abilities.
You likely can't join if
- severe cognitive impairment,
- aphasia,
- known presence of an epileptic seizure in the last year,
- other orthopaedic and neurological diseases affecting sensory or motor functions,
- inability to sit independently,
- severe visual impairment,
See the full eligibility criteria
- first ischaemic or hemorrhagic stroke,
- one-sided hemiparesis,
- adequate cognitive abilities.
- severe cognitive impairment,
- aphasia,
- known presence of an epileptic seizure in the last year,
- other orthopaedic and neurological diseases affecting sensory or motor functions,
- inability to sit independently,
- severe visual impairment,
- severe depression.
The study team makes the final eligibility decision.
Where it's taking place
- Ljubljana, Slovenia
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Ljubljana, Slovenia. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.